Continuing Medical Education - CME Courses

Popular

• • 

    

    Ezra Cohen, MD

    Peer

  • 

    

    Barbara Burtness, MD

    Peer

  1

  

  RestartResume

  Updates in Head and Neck Cancer Treatment: Integrating Checkpoint Inhibitor Therapy to Improve Outcomes

  Updates in Head and Neck Cancer Treatment: Integrating Checkpoint Inhibitor Therapy to Improve Outcomes

  0.25 credits

• • 

    

    David L. Eisenberg, MD, MPH, FACOG

    Peer

  • 

    

    David J. Portman, MD

    Peer

  2

  

  RestartResume

  Contraception: Focus on Vaginal pH Modulation

  Contraception: Focus on Vaginal pH Modulation

  0.25 credits

• • 

    

    Nanette F. Santoro, MD

    Peer

  9

  

  RestartResume

  Understanding Emerging Options for Managing Vasomotor Symptoms

  Understanding Emerging Options for Managing Vasomotor Symptoms

  0.25 credits

• • 

    

    Michael S. Ip, MD

    Peer

  • 

    

    Christina Y. Weng, MD, MBA

    Peer

  8

  

  RestartResume

  Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO

  Time Is Vision: Early Recognition and Management of Neovascular AMD and RVO

  0.25 credits

• • 

    

    Paul P. Doghramji, MD, FAAFP

    Peer

  • 

    

    Nina Delaney Wagner-Johnston, MD

    Peer

  • 

    

    Seema A. Bhat, MD

    Peer

  0

  

  RestartResume

  The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy

  The Evolving Landscape of Chronic Lymphocytic Leukemia: Selecting and Managing Targeted Therapy

  0.50 credits

• • 

    

    John Ryan, MD, MB, BCh, BAO, MRCPI, FACC, FAHA

    Peer

  3

  

  RestartResume

  The ABCs of CTD-PAH: (A)lgorithms, Team-(B)ased Approach, and (C)ombination Therapy

  The ABCs of CTD-PAH: (A)lgorithms, Team-(B)ased Approach, and (C)ombination Therapy

  1.25 credits

• • 

    

    Clete A. Kushida, MD, PhD

    Peer

  • 

    

    Michael J. Thorpy, MD

    Peer

  0

  

  RestartResume

  The Future of Narcolepsy Therapy: Its Likely Impact on Disease Burden and Patient Outcomes

  The Future of Narcolepsy Therapy: Its Likely Impact on Disease Burden and Patient Outcomes

  0.25 credits

• • 

    

    Diana Do, MD

    Peer

  • 

    

    Nancy M. Holekamp, MD

    Peer

  • 

    

    Carl Regillo, MD

    Peer

  0

  

  RestartResume

  On the Horizon: Achieving Durable VEGF Suppression in nAMD and DME

  On the Horizon: Achieving Durable VEGF Suppression in nAMD and DME

  0.50 credits

• • 

    

    Paul W. Armstrong, MD

    Peer

  • 

    

    Justin Ezekowitz, MD, MBBCh, MSc

    Peer

  3

  

  RestartResume

  Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness

  Emerging Data on New Therapy Combinations for HFrEF: Raising Clinician Awareness

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Anna-Barbara Moscicki, MD

    Peer

  7

  

  RestartResume

  Riding the Wave of Change in Cervical Cancer Screening: Managing Patients in Light of Risk Using Extended Genotyping

  Riding the Wave of Change in Cervical Cancer Screening: Managing Patients in Light of Risk Using Extended Genotyping

  0.25 credits

• • 

    

    Kevan C. Herold, MD

    Peer

  • 

    

    Andrea Steck, MD

    Peer

  • 

    

    Anette Gabriele Ziegler, MD

    Peer

  0

  

  RestartResume

  Changing Treatment Paradigms in Type 1 Diabetes:  Role of Anti-CD3 Targeted Therapy -

  Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D

  Changing Treatment Paradigms in Type 1 Diabetes:  Role of Anti-CD3 Targeted Therapy -

  Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D

  0.50 credits

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Johann de Bono, MB, ChB FRCP, MSc, PhD, FMedSci

    Peer

  • 

    

    Neeraj Agarwal, MD

    Peer

  3

  

  RestartResume

  Pulse Points in Prostate Cancer: Embracing Advances with PARPi Combinations

  Pulse Points in Prostate Cancer: Embracing Advances with PARPi Combinations

  0.75 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Jeffrey T. Jensen, MD, MPH

    Peer

  2

  

  RestartResume

  Applying Clinical Trial Data on Newer CHCs into Real-World Patient Care

  Applying Clinical Trial Data on Newer CHCs into Real-World Patient Care

  0.25 credits

• • 

    

    Peter K. Kaiser, MD

    Peer

  • 

    

    Dante J. Pieramici, MD

    Peer

  4

  

  RestartResume

  Neovascular AMD and RVO: Distinguishing the Differential

  Neovascular AMD and RVO: Distinguishing the Differential

  0.25 credits

• • 

    

    Emily Chew, MD

    Peer

  • 

    

    Neil Bressler, MD

    Peer

  • 

    

    Joseph M. Coney, MD

    Peer

  • 

    

    Steven Ferrucci, OD, FAAO

    Peer

  3

  

  RestartResume

  nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

  nAMD and RVO: Understanding the Impact on Patient Lives and the Need for Timely Diagnosis and Referral

  0.25 credits